BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 15796967)

  • 21. Dicentric chromosome in the bone marrow of a child with megakaryoblastic leukaemia and Down's syndrome.
    Wilkie AO; Kitchen C; Oakhill A; Howell RT; Berry PJ
    J Clin Pathol; 1988 Apr; 41(4):378-80. PubMed ID: 2966817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GATA1 mutations in patients with down syndrome and acute megakaryoblastic leukaemia do not always confer a good prognosis.
    Ariffin H; Garcia JC; Daud SS; Ibrahim K; Aizah N; Ong GB; Chong LA; Mohamad Z
    Pediatr Blood Cancer; 2009 Jul; 53(1):108-11. PubMed ID: 19260099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 15q24 microdeletion in transient myeloproliferative disease (TMD) and acute megakaryoblastic leukaemia (AMKL) implicates PML and SUMO3 in the leukaemogenesis of TMD/AMKL.
    Haemmerling S; Behnisch W; Doerks T; Korbel JO; Bork P; Moog U; Hentze S; Grasshoff U; Bonin M; Rieß O; Janssen JW; Jauch A; Bartram CR; Reinhardt D; Koch KA; Bandapalli OR; Kulozik AE
    Br J Haematol; 2012 Apr; 157(2):180-7. PubMed ID: 22296450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel mutation in the GATA1 gene associated with acute megakaryoblastic leukemia in a Korean Down syndrome patient.
    Kim IS; Park ES; Lim JY; Ki CS; Chi HS
    J Korean Med Sci; 2008 Dec; 23(6):1105-8. PubMed ID: 19119459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct gene signatures of transient and acute megakaryoblastic leukemia in Down syndrome.
    Lightfoot J; Hitzler JK; Zipursky A; Albert M; Macgregor PF
    Leukemia; 2004 Oct; 18(10):1617-23. PubMed ID: 15343346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS).
    Pelleri MC; Piovesan A; Caracausi M; Berardi AC; Vitale L; Strippoli P
    BMC Med Genomics; 2014 Dec; 7():63. PubMed ID: 25476127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.
    Wechsler J; Greene M; McDevitt MA; Anastasi J; Karp JE; Le Beau MM; Crispino JD
    Nat Genet; 2002 Sep; 32(1):148-52. PubMed ID: 12172547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
    Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A
    Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic studies in children with Down syndrome and acute leukemia.
    Valladares A; Palma-Padilla V; Mejía-Aranguré JM; Guevara-Yánez R; Lerma-Reyes A; Salamanca-Gómez F
    Leuk Res; 2005 Nov; 29(11):1241-6. PubMed ID: 16164980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype.
    Wang L; Peters JM; Fuda F; Li L; Karandikar NJ; Koduru P; Wang HY; Chen W
    Cytometry B Clin Cytom; 2015; 88(4):244-52. PubMed ID: 25361478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
    D'Angelo G; Merlo P
    Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute megakaryoblastic leukemia after transient myeloproliferative disorder with clonal karyotype evolution in a phenotypically normal neonate.
    Polski JM; Galambos C; Gale GB; Dunphy CH; Evans HL; Batanian JR
    J Pediatr Hematol Oncol; 2002 Jan; 24(1):50-4. PubMed ID: 11902741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient abnormal myelopoiesis in a Down syndrome newborn followed by acute myeloid leukemia: identification of the same chromosomal abnormality in both stages.
    Kitoh T; Taki T; Hayashi Y; Nakamura K; Irino T; Osaka M
    Cancer Genet Cytogenet; 2009 Jan; 188(2):99-102. PubMed ID: 19100513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Association of congenital chromosome abnormalities and malignant diseases].
    Erzsébet B; Andrea N; Róbert S; Eva O
    Orv Hetil; 1996 Feb; 137(5):227-31. PubMed ID: 8882440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
    Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
    Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome.
    Nikolaev SI; Santoni F; Vannier A; Falconnet E; Giarin E; Basso G; Hoischen A; Veltman JA; Groet J; Nizetic D; Antonarakis SE
    Blood; 2013 Jul; 122(4):554-61. PubMed ID: 23733339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder.
    Carpenter E; Valverde-Garduno V; Sternberg A; Mitchell C; Roberts I; Vyas P; Vora A
    Br J Haematol; 2005 Feb; 128(4):548-51. PubMed ID: 15686466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct clones are associated with the development of transient myeloproliferative disorder and acute megakaryocytic leukemia in a patient with Down syndrome.
    Kanegane H; Watanabe S; Nomura K; Xu G; Ito E; Miyawaki T
    Int J Hematol; 2007 Oct; 86(3):250-2. PubMed ID: 17988992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.
    Bourquin JP; Subramanian A; Langebrake C; Reinhardt D; Bernard O; Ballerini P; Baruchel A; Cavé H; Dastugue N; Hasle H; Kaspers GL; Lessard M; Michaux L; Vyas P; van Wering E; Zwaan CM; Golub TR; Orkin SH
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3339-44. PubMed ID: 16492768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.
    Heald B; Hilden JM; Zbuk K; Norton A; Vyas P; Theil KS; Eng C
    Nat Clin Pract Oncol; 2007 Jul; 4(7):433-8. PubMed ID: 17597708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.